Jharkhand Ties Up with Indian Pharmacopoeia Commission (IPC) | 17 Nov 2025

Why in News? 

The Indian Pharmacopoeia Commission (IPC) signed an MoU with the Jharkhand State Pharmacy Council (JSPC) to strengthen pharmacovigilance systems across Jharkhand. 

Key Points 

• About the Agreement: 
  • The MoU aims to strengthen the safe and rational use of medicines in the state by improving pharmacovigilance (drug safety monitoring) and materiovigilance (medical device safety). 
  • The agreement promotes wider adoption of the National Formulary of India (NFI) as a standard reference across healthcare institutions to support rational medication practices. 
  • Indian Pharmacopoeia Commission (IPC) will provide technical expertise, while Jharkhand State Pharmacy Council (JSPC) will mobilise pharmacists from public and private sectors to ensure effective implementation. 
• About Indian Pharmacopoeia Commission (IPC): 
  • IPC is an autonomous institution under the Ministry of Health & Family Welfare. 
  • It publishes the Indian Pharmacopoeia (IP), the official book of drug standards in India. 
  • It operates the Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI). 
  • It promotes patient safety, drug quality surveillance, and evidence-based medicine use. 
• About National Formulary of India (NFI): 
  • It is an official reference published by the Indian Pharmacopoeia Commission (IPC) to guide the rational and safe use of medicines. 
  • It provides standard information on approved drugs, including indications, dosages, contraindications and adverse effects, promoting uniform and evidence-based prescribing.